Jiyoung Yun

Dr. Jiyoung Yun


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
AKAryun Kim
Aryun Kim
YKYoung Eun Kim
Young Eun Kim
HKHan Joon Kim
Han Joon Kim
JYJiyoung Yun
Jiyoung Yun
HYHui-Jun Yang
Hui-Jun Yang
BJBeomseok Jeon
Beomseok Jeon

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JCJi-Hyun Choi
Ji-Hyun Choi
SLSeung Keun Lee
Seung Keun Lee
YGYoung-Eun Gil
Young-Eun Gil
JRJia Ryu
Jia Ryu
KJKyunghee Jung-Choi
Kyunghee Jung-Choi
JYJiyoung Yun
Jiyoung Yun
Choi JH, et al. J Korean Med Sci. 2017 Feb;32(2):371-376. https://doi.org/10.3346/jkms.2017.32.2.371

30 September 2018 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
EHEunyoung Han
Eunyoung Han
JYJiyoung Yun
Jiyoung Yun
Hyun Ju ChongHyun Ju Chong
Hyun Ju Chong
KCKyoung-Gyu Choi
Kyoung-Gyu Choi
Patients with Parkinson's disease (PD) frequently experience depression associated with voice problems. Singing involves the use of similar muscles and the neural networks associated with vocal function and emotional response. The purpose of this study is to enhance vocal quality and depressive symptoms of patients with PD using individual singing program. The Individual Therapeutic Singing Program for PD (ITSP-PD) was conducted by a certified music therapist. In total, nine PD patients with a subjective voice problem or depression participated in 6 sessions over 2 weeks. We measured the Maximum Phonation Time (MPT) via the Praat test, the Voice Handicap Index (VHI), the Voice-Related Quality of Life (V-RQOL) and the Geriatric Depression Scale (GDS). In total, 8 out of 9 patients completed all the sessions; 6 out of 8 patients participated in the follow-up test after 6 months. A statistically significant change in MPT (p = 0.011) was observed between the pre- and post-tests. The VHI (p = 0.035) and the GDS (p = 0.018) were significantly lower in the post-test. In the pre-, post-, and follow-up tests, the MPT (p = 0.030), V-RQOL (p = 0.008), and GDS (p = 0.009) were significantly changed. The ITSP-PD based on neurological singing therapy for PD showed therapeutic possibility for vocal function and depression in patients with PD. Our findings suggest the need for a randomized study to examine the continuing positive effects of the ITSP-PD over a longer period of time.

1 August 2012 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
HKHan Joon Kim
Han Joon Kim
BJBeom S. Jeon
Beom S. Jeon
JLJee-Young Lee
Jee-Young Lee
JYJiyoung Yun
Jiyoung Yun
YKYoung Eun Kim
Young Eun Kim
SPSun Ha Paek
Sun Ha Paek

1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
HYHui-Jun Yang
Hui-Jun Yang
HKHan Joon Kim
Han Joon Kim
SKSeong-Beom Koh
Seong-Beom Koh
JKJoong-Seok Kim
Joong-Seok Kim
TATae-Beom Ahn
Tae-Beom Ahn
SKSang Jin Kim
Sang Jin Kim
Background and Purpose This study aimed to determine the clinimetric properties of the Korean version of Parkinson's Disease Sleep Scale-2 (K-PDSS-2) and whether distinct subtypes of sleep disturbance can be empirically identified in patients with Parkinson's disease (PD) using the cross-culturally validated K-PDSS-2. Methods The internal consistency, test-retest reliability, scale precision, and convergent validity of K-PDSS-2 were assessed in a nationwide, multicenter study of 122 patients with PD. Latent class analysis (LCA) was used to derive subgroups of patients who experienced similar patterns of sleep-related problems and nocturnal disabilities. Results The total K-PDSS-2 score was 11.67 +/- 9.87 (mean +/- standard deviation) at baseline and 12.61 +/- 11.17 at the retest. Cronbach's a coefficients of the total K-PDSS-2 scores at baseline and follow-up were 0.851 and 0.880, respectively. The intraclass correlation coefficients over the 2-week study period ranged from 0.672 to 0.848. The total K-PDSS-2 score was strongly correlated with health-related quality of life measures and other corresponding nonmotor scales. LCA revealed three distinct subtypes of sleep disturbance in the study patients: "less-troubled sleepers:," "PD-related nocturnal difficulties," and "disturbed sleepers". Conclusions K-PDSS-2 showed good clinimetric attributes in accordance with previous studies that employed the original version of the PDSS-2, therefore confirming the cross-cultural usefulness of the scale. This study has further documented the first application of an LCA approach for identifying subtypes of sleep disturbance in patients with PD.

10 March 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
SJSuok Jeon
Suok Jeon
SLSu-A Lee
Su-A Lee
HCHae-Sun Chung
Hae-Sun Chung
JYJiyoung Yun
Jiyoung Yun
EPEun Ae Park
Eun Ae Park
Jungwon HuhJungwon Huh
Jungwon Huh
Background/Objectives: Rare diseases often present challenges in obtaining reliable and accurate information than common diseases owing to their low prevalence. Patients and families often rely on self-directed learning, but understanding complex medical information can be difficult, increasing the risk of misinformation. This study aimed to evaluate whether generative artificial intelligence (AI) provides accurate and non-harmful answers to rare disease-related questions and assesses its utility in supporting patients and families requiring genetic counseling. Methods: We evaluated four generative AI models available between 22 September and 4 October 2024: ChatGPT o1-Preview, Gemini advanced, Claude 3.5 sonnet, and Perplexity sonar huge. A total of 102 questions targeting four rare diseases, covering general information, diagnosis, treatment, prognosis, and counseling, were prepared. Four evaluators scored the responses for professionalism and accuracy using the Likert scale (1: poor, 5: excellent). Results: The average scores ranked the AI models as: ChatGPT (4.24 ± 0.73), Gemini (4.15 ± 0.74), Claude (4.13 ± 0.82), and Perplexity (3.35 ± 0.80; p < 0.001). Perplexity had the highest proportion of scores of 1 (very poor) and 2 (poor) (7.6%, 31/408), followed by Gemini (2.0%, 8/408), Claude (1.5%, 6/408), and ChatGPT (1.5%, 6/408). The accuracy of responses in the counseling part across all four diseases was significantly different (p < 0.001). Conclusions: The four generative AI models generally provided reliable information. However, occasional inaccuracies and ambiguous references may lead to confusion and anxiety among patients and their families. To ensure its effective use, recognizing the limitations of generative AI and providing guidance from experts regarding its proper utilization is essential.